McKiernan Fergus E
Center for Bone Diseases, Marshfield Clinic, 1000 North Oak, Marshfield, WI 54449, USA.
Curr Rheumatol Rep. 2007 Apr;9(1):57-65. doi: 10.1007/s11926-007-0023-0.
The absence of Level I evidence undermines the credibility of all clinical studies pertaining to percutaneous vertebral augmentation (ie, kyphoplasty and vertebroplasty). The powerful desire to relieve suffering in the frail elderly cannot substitute for a rigorously designed randomized controlled trial comparing vertebral augmentation with continued nonoperative care. Though the level of available evidence is currently inadequate, its quality is improving.
缺乏一级证据削弱了所有与经皮椎体强化术(即椎体后凸成形术和椎体成形术)相关临床研究的可信度。减轻体弱老年人痛苦的强烈愿望不能替代一项设计严谨的随机对照试验,该试验需比较椎体强化术与持续非手术治疗的效果。尽管目前可用证据的水平不足,但其质量正在提高。